Skip to main content
Equibles

4564 · OncoTherapy Science, Inc. · Financials

Use 4564 with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research 4564.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
16 JPY -1 (-5.88%) At close · Nov 13
Rebalance outlook locked
Market Cap
6.53B JPY
Shares
408.24M
Volume · Nov 13 195.65M Avg daily vol (3M) 188.86M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
808.53M +7.8%
FY2026 Revenue FY2022–FY2026
Net Income
-910.64M -11.7%
FY2026 Net Income FY2022–FY2026
Operating Margin
-100.23% +6.2pp
FY2026 Operating Margin FY2022–FY2026
Operating Cash Flow
-922.75M -13.2%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2026 FY2025 FY2024 FY2023 FY2022
JPY 808.53M 750.05M 610.12M 1.13B 1.15B
JPY -810.39M -797.94M -1.12B -1.11B -2.05B
JPY -908.48M -813.13M -1.29B -1.12B -2.57B
JPY 2.16M 2.16M 2.43M 2.22M 1.23M
JPY -910.64M -815.29M -1.29B -1.12B -2.57B
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.